Acurx Pharmaceuticals, Inc. (ACXP) stock forecast and price target
Price $0.96 · data as of November 13, 2026
12-month price target
Average target$10.33
Upside / downside+976.4%
Analysts3
ConsensusStrong buy
Low $10.00Average $10.33High $11.00
Gold marker: average target · white marker: today’s price ($0.96)
Analyst ratings
Strong buy 1Buy 2Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.02 | +62.1% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.78 | +11.7% | $0 |
| Next quarter ends December 31, 2026 | $-0.45 | −43.5% | $0 |
| Quarter after ends March 31, 2027 | $-0.43 | +30.6% | $0 |
Consensus of the analysts covering Acurx Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Acurx Pharmaceuticals stock price target?
The average 12-month target from 3 analysts is $10.33, 976.4% above the current price of $0.96 Targets range from $10.00 to $11.00.
Is Acurx Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 2 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Acurx Pharmaceuticals expected to earn?
Analysts expect EPS of $-2.02 for the fiscal year ending December 31, 2026 and $-1.78 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.